<p>Changes in BMF gene expression between OXA treated (T) and non-treated (NT) HT29, siPKM2- HT29 and HTOXAR3 cells. Vertical bars in the graphics represent means obtained from at least 3 independent experiments ± SD. B. Percentage of dead cells after treatment with oxaliplatin and/or BMF gene knockdown. Bars represent means obtained from at least 3 independent experiments ± SD. The Little graph shows percentage (mean ± SD) of BMF expression inhibition after siRNA transfections. * <i>P- value</i> < 0.05. ** <i>P-value <</i> 0.01; *** <i>P-value <</i> 0.001</p
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
<p>To determine the ability of Fas to induce cell death, cells were treated or not with A) oxaliplat...
<p>A) MMP7 expression was inhibited by siRNA and then treated with different doses of oxaliplatin in...
<p>A. 3-D plot showing fold changes in expression patterns after treatment with 10 μM OXA in HT29, s...
<p>Most relevant changes in cell death genes expression patterns after treatment with OXA and/or PKM...
<p>Bars represent the IC50 ± SD (average values from at least three independent experiments) for oxa...
<p>After siRNA transfection cells were treated with 15 μM OXA for 24 h period, observed by optical m...
The platinum compound oxaliplatin has been shown to be an effective chemotherapeutic agent for the t...
The BRD9 bromodomain regulates transcription of AML- and hematopoiesis-associated genes. A, Volcano ...
<p>Directional fold-change values for a subset of gene, related to tumor aggressiveness identified i...
AIM: To study the effect of oxaliplatin on the survival rate of Y79 after down-regulation of Mcl-1 b...
, SK-N-SH cells lacking TF expression were transfected with the expression plasmid pcDNA3.1/TF and c...
. western blot assay for expression of TF in two neuroblastoma cell lines SH-EP1 and SK-N-SH. Actin ...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
Inhibition of the BRD9 bromodomain selectively kills AML cells but not HEK293T cells. A, Growth assa...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
<p>To determine the ability of Fas to induce cell death, cells were treated or not with A) oxaliplat...
<p>A) MMP7 expression was inhibited by siRNA and then treated with different doses of oxaliplatin in...
<p>A. 3-D plot showing fold changes in expression patterns after treatment with 10 μM OXA in HT29, s...
<p>Most relevant changes in cell death genes expression patterns after treatment with OXA and/or PKM...
<p>Bars represent the IC50 ± SD (average values from at least three independent experiments) for oxa...
<p>After siRNA transfection cells were treated with 15 μM OXA for 24 h period, observed by optical m...
The platinum compound oxaliplatin has been shown to be an effective chemotherapeutic agent for the t...
The BRD9 bromodomain regulates transcription of AML- and hematopoiesis-associated genes. A, Volcano ...
<p>Directional fold-change values for a subset of gene, related to tumor aggressiveness identified i...
AIM: To study the effect of oxaliplatin on the survival rate of Y79 after down-regulation of Mcl-1 b...
, SK-N-SH cells lacking TF expression were transfected with the expression plasmid pcDNA3.1/TF and c...
. western blot assay for expression of TF in two neuroblastoma cell lines SH-EP1 and SK-N-SH. Actin ...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
Inhibition of the BRD9 bromodomain selectively kills AML cells but not HEK293T cells. A, Growth assa...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
<p>To determine the ability of Fas to induce cell death, cells were treated or not with A) oxaliplat...
<p>A) MMP7 expression was inhibited by siRNA and then treated with different doses of oxaliplatin in...